MSD vs. TMO
Compare and contrast key facts about Morgan Stanley Emerging Markets Debt Fund, Inc. (MSD) and Thermo Fisher Scientific Inc. (TMO).
Performance
MSD vs. TMO - Performance Comparison
Loading graphics...
MSD vs. TMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MSD Morgan Stanley Emerging Markets Debt Fund, Inc. | -3.10% | 5.58% | 24.92% | 19.14% | -22.10% | 2.20% | 0.73% | 24.38% | -12.31% | 16.33% |
TMO Thermo Fisher Scientific Inc. | -14.57% | 11.78% | -1.72% | -3.36% | -17.29% | 43.54% | 43.72% | 45.55% | 18.21% | 35.03% |
Fundamentals
MSD:
$142.02M
TMO:
$186.44B
MSD:
$1.85
TMO:
$17.77
MSD:
3.79
TMO:
27.83
MSD:
3.68
TMO:
4.19
MSD:
0.89
TMO:
3.49
MSD:
$38.58M
TMO:
$44.56B
MSD:
$35.05M
TMO:
$18.02B
MSD:
$30.02M
TMO:
$11.35B
Returns By Period
In the year-to-date period, MSD achieves a -3.10% return, which is significantly higher than TMO's -14.57% return. Over the past 10 years, MSD has underperformed TMO with an annualized return of 5.35%, while TMO has yielded a comparatively higher 13.56% annualized return.
MSD
- 1D
- 0.72%
- 1M
- -7.36%
- YTD
- -3.10%
- 6M
- -0.84%
- 1Y
- -4.80%
- 3Y*
- 14.71%
- 5Y*
- 4.27%
- 10Y*
- 5.35%
TMO
- 1D
- 0.61%
- 1M
- -2.66%
- YTD
- -14.57%
- 6M
- -6.66%
- 1Y
- 2.77%
- 3Y*
- -4.68%
- 5Y*
- 1.90%
- 10Y*
- 13.56%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MSD vs. TMO — Risk / Return Rank
MSD
TMO
MSD vs. TMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Morgan Stanley Emerging Markets Debt Fund, Inc. (MSD) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MSD | TMO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.36 | 0.09 | -0.45 |
Sortino ratioReturn per unit of downside risk | -0.38 | 0.38 | -0.76 |
Omega ratioGain probability vs. loss probability | 0.94 | 1.04 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | -0.20 | -0.01 | -0.20 |
Martin ratioReturn relative to average drawdown | -0.52 | -0.02 | -0.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| MSD | TMO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.36 | 0.09 | -0.45 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.07 | +0.24 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.52 | -0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.41 | -0.06 |
Correlation
The correlation between MSD and TMO is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
MSD vs. TMO - Dividend Comparison
MSD's dividend yield for the trailing twelve months is around 9.26%, more than TMO's 0.36% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MSD Morgan Stanley Emerging Markets Debt Fund, Inc. | 9.26% | 9.88% | 11.88% | 10.90% | 7.34% | 4.99% | 4.67% | 5.37% | 6.56% | 5.81% | 6.87% | 7.03% |
TMO Thermo Fisher Scientific Inc. | 0.36% | 0.30% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% |
Drawdowns
MSD vs. TMO - Drawdown Comparison
The maximum MSD drawdown since its inception was -58.51%, smaller than the maximum TMO drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for MSD and TMO.
Loading graphics...
Drawdown Indicators
| MSD | TMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.51% | -71.16% | +12.65% |
Max Drawdown (1Y)Largest decline over 1 year | -12.84% | -27.31% | +14.47% |
Max Drawdown (5Y)Largest decline over 5 years | -33.89% | -40.95% | +7.06% |
Max Drawdown (10Y)Largest decline over 10 years | -37.50% | -40.95% | +3.45% |
Current DrawdownCurrent decline from peak | -9.70% | -24.98% | +15.28% |
Average DrawdownAverage peak-to-trough decline | -11.33% | -17.97% | +6.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.08% | 12.13% | -7.05% |
Volatility
MSD vs. TMO - Volatility Comparison
The current volatility for Morgan Stanley Emerging Markets Debt Fund, Inc. (MSD) is 4.88%, while Thermo Fisher Scientific Inc. (TMO) has a volatility of 8.84%. This indicates that MSD experiences smaller price fluctuations and is considered to be less risky than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| MSD | TMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.88% | 8.84% | -3.96% |
Volatility (6M)Calculated over the trailing 6-month period | 7.28% | 19.06% | -11.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.51% | 32.87% | -19.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.92% | 26.59% | -12.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.67% | 25.93% | -11.26% |
Financials
MSD vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Morgan Stanley Emerging Markets Debt Fund, Inc. and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities